Ventricular Arrythmia
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
AbbottABBOTT PARK, IL
2 programsFixed TiltN/A1 trial
Temporary implantation of defibrillation coils and pulse generatorN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Precision BioSciencesVIVO
AbbottTemporary implantation of defibrillation coils and pulse generator
AbbottFixed Tilt
Clinical Trials (3)
Total enrollment: 934 patients across 3 trials
VIVO European Observational Registry
Start: Oct 2021Est. completion: Sep 2024125 patients
N/ACompleted
Non-vascular ICD Electrode Configuration Feasibility Study
Start: Mar 2021Est. completion: Mar 202230 patients
N/ACompleted
Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Implantable-Cardioverter Population
Start: Jun 2018Est. completion: Apr 2025779 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space